In this in-depth report, we explore how personalized medicine and disruptive technology such as AI, blockchain and advanced analytics are changing the life sciences temperature controlled supply chain landscape. 

If you would like a copy sent directly to you, please contact us here.

For over a decade, we at Cold Chain Global Forum have been dedicated to connecting and educating supply chain leaders from across the biopharma world from small, biotech startups to publicly traded Big Pharma manufacturers. In an effort to shed light on where the industry is heading in 2019, we surveyed 150+ life sciences logistics leaders on:

• What's Trending in 2019?
• Lessons learnt from their end-to-end temperature controlled supply chain optimization journeys
• Their biggest challenges and strategic priorities over the next 12 months
• Top areas of investment when it comes to solution providers and vendors

If you would like a copy sent directly to you, please contact us here.

The following article by Nick Basta, Editor in Chief, Managing Partner and Founder of Pharmaceutical Commerce, lists out the factors that should go into every evaluation of supply chain options.

If you would like a copy sent directly to you, please contact us here.

The pharmaceutical supply chain requires a myriad of partners to work as a cohesive unit. However, this is not always the case. Most companies have relationships built between different stakeholders at different times, competing agendas leadings to a variety of demands on vendors and an overlap of services from a lack of overarching strategy.

Together, this is creating inefficiency, hindering innovation and adding additional effort to overstretched supply chain leaders. But, there is a way for your vendors to start doing more for you, integrating more effectively with your operations and bringing forward new ideas. It simply requires collaboration.

This is often easier said that done. So we reached out to two industry experts; Bruce Guenter, Director of Logistics and Distribution at Radius Health and Rick Calabrese, Global Director of Corporate Quality Systems at Sartorius. They have shared insight with us on the steps needed to improve your vendor collaboration, how to balance the cost vs quality dynamic and where you can leverage your network to improve collaboration.

If you would like a copy sent directly to you, please contact us here.

For those just starting out in temperature controlled supply, it can seem like a daunting task. With a complex vendor landscape, pressing operational challenges and a multitude of risks factors, it is far from an easy project.

To help you succeed from the start, we spoke to Kevin Hickman, Senior Manager of Supply Chain Distribution at Gilead Sciences. With over 26 years of experience in commercial and clinical pharma and biopharma transport management, he shares the cold chain critical success factors you need to know.

If you would like a copy sent directly to you, please contact us here.

The pharmaceutical industry is witnessing a period of high innovation, with new technologies emerging set to drastically impact the way we operate the supply chain. The proposed applications for drones, artificial intelligence, data analytics and blockchain are numerous. Currently, though, application has been fragmented as people set out to explore this new technology without regulatory guidance or best practices.

In this handy infographic, we share a framework to guide your implementation and evaluation of new technology for the supply chain. We also offer insight from those who have made an innovative change to their supply chain, including an exclusive case study on the latest ambulance drone technology.

If you would like a copy sent directly to you, please contact us here.

At the 17th Annual Cold Chain Global Forum, we met with John Crowley, Chairman and CEO of Amicus Therapeutics where he answered some questions including:

• Where are the macro pressures that are affecting the cold chain industry that will have a direct impact over the next 12 months?
• What keeps you up at night about cold chain and how are you going to fix it?
• How is the industry going to achieve the optimal equilibrium between patient centricity, operational and cost efficiency?
• What are your top priorities over the next 12 months?

If you would like a copy sent directly to you, please contact us here.